The balance between RANKL and OPN expression serves a key role in osteoclast differentiation and function, where dysregulation of the ratio between the two has been found in a variety of bone metabolism diseases such as postmenopausal osteoporosis [19–21]. Here, TNFSF11 is linked to postmenopausal osteoporosis.